Oscar Tahuahua, Medical Oncology fellow at National Cancer Institute, shared an article by Eric Lim on X:
“A Perspective on the MARS2 Trial.
Is mesothelioma a surgical disease?
The MARS2 trial shows higher mortality and adverse events without improving survival. Risks increase outside high-volume centers, limiting benefits to specific subgroups.”
A Perspective on the MARS2 Trial.
Authors: Eric Lim, et al.
